Implications
metabolic impairments
OBESE, STILL, CARDIOVASCULAR DISEASES, MINOR, DISEASES
If replicated, the current findings carry clinical implications for screening and treatment of BN and BED. Although few of our participants were categorized as obese, and the mean levels of metabolic parameters were within normal levels, a high frequency of metabolic impairments was identified in these young females. As such, clinicians should identify and treat clinical levels of, e.g., blood lipids and blood glucose in patients with BN or BED to reduce their risk for cardiovascular diseases. Females with BED seem as a core target group as they showed a worse one-year cholesterol profile. During the short follow-up period of 1 year, the increase in mean lipid levels was of minor clinical concern. Still, considering the young age as in the current sample, improved screening procedure may offer longer-term health preventive benefits. The simple addition of ordering lipid assessment in connection with blood samples that the clinical staff already routinely orders, should interfere little with the faster pace of clinical practice. Based on the existing knowledge of increased risk for non-communicable diseases in women with BN or BED [